Theorem Clinical Research

Theorem optimizes services for regulatory and clinical issues

Wednesday, October 10, 2012 09:22 AM

Theorem Clinical Research, a King of Prussia, Penn.-based full-service CRO that provides core clinical R&D services, also helps clients identify and strategically address early and ongoing device-related regulatory and clinical issues.

More... »

Theorem and Gallus ink exclusive partnership

Wednesday, August 8, 2012 10:15 AM

Theorem Clinical Research, a global provider of comprehensive clinical research and development services, has entered an exclusive partnership with Gallus BioPharmaceuticals, a contract manufacturing company based in St. Louis, Mo., to help both companies accelerate their research, development and manufacturing of biopharmaceuticals.

More... »

Theorem relocates headquarters to accommodate growth

Thursday, August 2, 2012 12:24 PM

Theorem Clinical Research, a midsize CRO that provides core clinical research and development services, has relocated its headquarters 1.5 miles from the original site in King of Prussia, Penn., where the company has been located for the past 10 years.

More... »

Theorem names Rosenfeld as vice president

Friday, March 23, 2012 03:28 PM

Theorem Clinical Research, a full-service CRO, has appointed Evan Rosenfeld, M.D., J.D., F.C.L.M., as vice president of medical and scientific affairs, medical device and diagnostics.

More... »

Theorem names VP, EMEA

Wednesday, November 16, 2011 02:19 PM

Theorem Clinical Research, previously Omnicare Clinical Research, has named Christian Tucat vice president & general manager, Europe Middle East & Africa. In this role, Tucat will have direct accountability for sales and the P&L of Theorem’s business in these regions.

More... »

Hoffman joins Theorem Clinical Research

Tuesday, November 8, 2011 03:35 PM

Theorem Clinical Research, previously Omnicare Clinical Research, has named Marc Hoffman, MD, senior vice president and general manager for their newly formed pharmaceutical development business unit. In his new role, Hoffman will have strategic oversight for Theorem’s core CRO operation, including project management, clinical monitoring, SMART (site management and patient recruitmenT), and pharmaceutics. He will also oversee the company’s medical operations. 

More... »

CRO top executives in a game of ‘musical chairs’

Monday, November 7, 2011 08:02 AM

Five months after INC Research’s acquisition of Kendle International closed, executives from the now-combined CRO are landing jobs with competitors.  

More... »

Potthoff named president, CEO of Theorem Clinical Research

Wednesday, November 2, 2011 01:13 PM

John Potthoff has stepped down as chief operating officer of CRO INC Research to become president and CEO of Theorem Clinical Research, succeeding James Pusey, who now becomes Theorem’s executive chairman to the board of directors.

More... »

Theorem names VP, global business development

Thursday, October 27, 2011 12:22 PM

Theorem Clinical Research, previously Omnicare Clinical Research, has named Adam Serody vice president, global business development. In his new role, Serody will lead Theorem’s global sales, proposals and marketing organizations.

More... »

Omnicare re-brands as Theorem Clinical Research

Thursday, June 16, 2011 10:29 AM

CRO Omnicare Clinical Research, based in King of Prussia, Penn., has re-branded the company under the name Theorem Clinical Research. The brand launch marks the final step in the CRO's separation from its former parent company in a deal that was finalized this spring.

More... »